Skip to main content
NIH funding notice PAR-19-298

Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional)

Closed on September 7, 2022.

Posted
June 14, 2019
Close date
September 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,529,312 in first-year total cost, median $762,105.

Most frequent study sections

  1. Emerging Imaging Technologies in Neuroscience Study Section[EITN]2
  2. Special Emphasis Panel[ZRG1 ETTN-Q (91)]2
  3. Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section[BNVT]1
  4. Special Emphasis Panel[ZRG1 ETTN-B (51)]1
  5. Special Emphasis Panel[ZRG1 NV-Q (91)]1

Most frequent institutions

  1. ALBERT EINSTEIN COLLEGE OF MEDICINE1
  2. HEBREW REHABILITATION CENTER FOR AGED1
  3. JOHNS HOPKINS UNIVERSITY1
  4. MASSACHUSETTS GENERAL HOSPITAL1
  5. MEDICAL UNIVERSITY OF SOUTH CAROLINA1
Competing awards under PAR-19-298 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Transcranial Magnetic Stimulation for MCI: A Phase II Dose-Response Study1R01AG081237-01BENITEZ, ANDREANAMEDICAL UNIVERSITY OF SOUTH CAROLINA, SC$748,467ZRG1
2022Multifocal transcranial current stimulation for cognitive and motor dysfunction in dementia1R01AG076708-01MANOR, BRADLEY D.PASCUAL-LEONE, ALVAROHEBREW REHABILITATION CENTER FOR AGED, MA$762,105ZRG1
2022Gamma-Music Based Intervention for Mild Alzheimer's Disease1R01AG078376-01LARGE, EDWARD WLOUI, PSYCHENORTHEASTERN UNIVERSITY, MA$545,725ZRG1
2021The wandering nerve: gateway to boost Alzheimer's disease related cognitive performance1R01AG068062-01A1JACOBS, HEIDI IRMAMASSACHUSETTS GENERAL HOSPITAL, MA$838,407BNVT
2020Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial1R01AG068167-01KNOTKOVA, HELENAVERGHESE, JOEALBERT EINSTEIN COLLEGE OF MEDICINE, NY$1,138,419EITN
2020Transcranial direct current stimulation in typical and atypical Alzheimer's disease1R01AG068881-01TSAPKINI, KYRANAJOHNS HOPKINS UNIVERSITY, MD$781,365EITN
2020Network-targeted theta-burst stimulation for episodic memory improvement in mild cognitive impairment1R01AG068317-01LEUCHTER, ANDREW FSUTHANA, NANTHIA AUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$714,824ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-298: Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) | ScienceDex | ConductScience